Abstract
Chronic rhinosinusitis (CRS) is characterized by persistent symptomatic inflammation of the nasal and paranasal mucosa that lasts longer than 12 weeks. This inflammatory disease of the paranasal sinuses affects 10–15% of US and European populations. CRS patients who are refractory to optimal medical management are candidates for functional endoscopic sinus surgery (FESS). Success rate of FESS may be as high as 90% in Chronic Rhinosinusitis patients without polyps (CRSsNP) and drop to the level of less than 30% in CRS patients with nasal polyps (CRSwNP). Multiple factors contribute to the need for revision endoscopic sinus surgery (RESS) including surgical technique, extent of disease, anatomic obstruction, and postoperative care. When maximal appropriate medical therapy has failed revision surgery must focus on maximizing quality-of-life outcomes. The preoperative analysis begins with a thorough in-office endoscopic examination combined with thin-cut sinus computed tomography scan (axial, coronal, and sagittal views), to allow a triplanar assessment of the postsurgical sinonasal cavities. It is essential to evaluate the most constant standard anatomical landmarks helpful in RESS for the different paranasal sinuses to approach. Postoperative management of RESS is as important as surgery. Postoperative debridments are controversial in the management of scar formation. Irrigations with saline or steroid added irrigations are very helpful for CRS with nasal polyposis. EFRS patients may benefit from systemic steroids for approximately 12 weeks in a tapered fashion. Topical nasal steroids are shown to be effective in randomised clinical trials and continued for a longer time up to 6 months.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fokkens WJ, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;50:1–298.
Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study. Allergy. 2011;66:1216–23.
Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for US adults. Vital Health Stat. 2014;10(260):1–161.
Vlaminck S, Vauterin T, Hellings PW, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis. Am J Rhinol Allergy. 2014;28(3):260–4.
Sillers M, Lay K. Principles of revision functional endoscopic sinus surgery. Oper Tech Otolaryngol. 2016;17(1):6–12.
Soler ZM, Hyer JM, Rudmik L, et al. Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. J Allergy Clin Immunol. 2016;137:1054–62.
Palmer JN, Kennedy DW. Revision endoscopic sinus surgery. Philadelphia, PA: Elsevier Mosby; 2005.
Stankiewicz JA, Donzelli JJ, Chow JM. Failures of functional endoscopic sinus surgery and their surgical correction. Oper Tech Otolaryngol. 1996;7(3):297–304.
Otto KJ, DelGaudio JM. Operative findings in the frontal recess at time of revision surgery. Am J Otolaryngol. 2010;31(3):175–80.
Sacks PL, Snidvongs K, Rom D, et al. The impact of neo-osteogenesis on disease control in chronic rhinosinusitis after primary surgery. Int Forum Allergy Rhinol. 2013;3(10):823–7.
Richtsmeier WJ. Top 10 reasons for endoscopic maxillary sinus surgery failure. Laryngoscope. 2001;111(11 Pt 1):1952–6.
Rudmik L, Smith TL. Evidence-based practice: postoperative care in endoscopic sinus surgery. Otolaryngol Clin N Am. 2012;45(5):1019–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Göde, S., Midilli, R., Vlaminck, S. (2020). Revision Sinus Surgery. In: Cingi, C., Bayar Muluk, N. (eds) All Around the Nose. Springer, Cham. https://doi.org/10.1007/978-3-030-21217-9_64
Download citation
DOI: https://doi.org/10.1007/978-3-030-21217-9_64
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21216-2
Online ISBN: 978-3-030-21217-9
eBook Packages: MedicineMedicine (R0)